{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:47:06Z","timestamp":1791190026119,"version":"4.1.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPD"],"published-print":{"date-parts":[[2011,6,1]]},"DOI":"10.2174\/138161211796390976","type":"journal-article","created":{"date-parts":[[2011,7,11]],"date-time":"2011-07-11T06:12:34Z","timestamp":1310364754000},"page":"1818-1824","source":"Crossref","is-referenced-by-count":196,"title":["Phosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure"],"prefix":"10.2174","volume":"17","author":[{"given":"Toshinori","family":"Aoyagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/74650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T09:00:33Z","timestamp":1448010033000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1381-6128&volume=17&issue=18&spage=1818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,1]]},"references-count":0,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2011,6,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/138161211796390976","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,1]]}}}